Physician profile
Lisa Nassif Wright
NPI 1780858167
$4,858.26
in general payments reported to CMS, 2019-2025
45 companies · $1,062 in 2025
The $1,062 reported for 2025 was more than what a typical Neurology With Special Qualifications In Child Neurology provider received nationally (typical 2025 total: $275).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $120 · 2020: $20.66 · 2021: $528 · 2022: $706 · 2023: $838 · 2024: $1,583 · 2025: $1,062.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,982 · Consulting Fee: $500 · Education: $1.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,981.88 |
| Consulting Fee | $500.00 |
| Education | $1.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $669.55 | 2022-2025 | Briviact, Fintepla, Rystiggo |
| Tg Therapeutics, INC. | $500.00 | 2024 | |
| Sk Life Science, INC. | $477.47 | 2022-2025 | Xcopri |
| Biogen, INC. | $455.81 | 2021-2025 | Vumerity, Tysabri, Spinraza |
| Lilly USA, LLC | $359.06 | 2022-2025 | Kisunla, Amyvid, Emgality |
| Neurocrine Biosciences, INC. | $194.64 | 2019-2024 | Ingrezza, Ongentys |
| Aquestive Therapeutics, INC. | $168.09 | 2021-2022 | |
| Lundbeck LLC | $150.27 | 2021-2025 | Vyepti |
| Grifols USA, LLC | $148.24 | 2023-2025 | Gamunex-C |
| Livanova USA, INC. | $141.33 | 2021-2023 | Vns Therapy Sentiva Model 1000 Generator |
| Impel Pharmaceuticals LLC | $141.31 | 2025 | Trudhesa |
| Argenx US, INC. | $134.06 | 2023-2025 | Vyvgart, Vyvgart Hytrulo |
| Teva Pharmaceuticals USA, INC. | $112.34 | 2023-2025 | Ajovy, Austedo Xr, Austedo Xr |
| Acadia Pharmaceuticals INC | $109.76 | 2021-2024 | Nuplazid |
| Jazz Pharmaceuticals INC. | $105.51 | 2021-2023 | Xywav |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Nassif Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.